87.29
price up icon1.02%   0.88
after-market Handel nachbörslich: 87.88 0.59 +0.68%
loading
Schlusskurs vom Vortag:
$86.41
Offen:
$86.66
24-Stunden-Volumen:
860.76K
Relative Volume:
0.96
Marktkapitalisierung:
$14.86B
Einnahmen:
$8.28B
Nettoeinkommen (Verlust:
$1.43B
KGV:
10.69
EPS:
8.1642
Netto-Cashflow:
$-203.00M
1W Leistung:
-0.64%
1M Leistung:
-3.04%
6M Leistung:
+31.90%
1J Leistung:
+21.57%
1-Tages-Spanne:
Value
$86.66
$88.23
1-Wochen-Bereich:
Value
$85.25
$88.93
52-Wochen-Spanne:
Value
$62.38
$94.16

Solventum Corp Stock (SOLV) Company Profile

Name
Firmenname
Solventum Corp
Name
Telefon
651-733-1110
Name
Adresse
1750 YANKEE DOODLE ROAD, EAGAN
Name
Mitarbeiter
20,000
Name
Twitter
Name
Nächster Verdiensttermin
2026-11-05
Name
Neueste SEC-Einreichungen
Name
SOLV's Discussions on Twitter

Compare SOLV vs ISRG, BDX, RMD, MDLN, ALC

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
SOLV icon
SOLV
Solventum Corp
87.29 14.86B 8.28B 1.43B -203.00M 8.1642
ISRG icon
ISRG
Intuitive Surgical Inc
423.96 149.78B 11.03B 3.16B 3.22B 8.7251
BDX icon
BDX
Becton Dickinson Co
183.75 50.05B 21.37B 1.41B 3.07B 3.9437
RMD icon
RMD
Resmed Inc
230.05 32.35B 5.54B 1.52B 1.74B 10.37
MDLN icon
MDLN
Medline Inc
36.26 31.81B 29.14B 1.07B 1.05B 1.1956
ALC icon
ALC
Alcon Inc
64.11 30.99B 10.63B 819.00M 1.59B 1.6577

Solventum Corp Stock (SOLV) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2026-07-28 Hochstufung UBS Neutral → Buy
2026-07-09 Eingeleitet BMO Capital Markets Market Perform
2026-05-15 Eingeleitet Wedbush Outperform
2026-05-14 Herabstufung UBS Buy → Neutral
2026-03-24 Eingeleitet Rothschild & Co Redburn Sell
2026-01-26 Hochstufung KeyBanc Capital Markets Sector Weight → Overweight
2026-01-20 Hochstufung Mizuho Neutral → Outperform
2025-12-02 Hochstufung BTIG Research Neutral → Buy
2025-10-01 Eingeleitet UBS Neutral
2025-09-11 Eingeleitet Jefferies Hold
2025-07-15 Hochstufung Morgan Stanley Equal-Weight → Overweight
2025-07-01 Hochstufung Argus Hold → Buy
2025-06-06 Eingeleitet KeyBanc Capital Markets Sector Weight
2025-05-19 Hochstufung Piper Sandler Neutral → Overweight
2024-12-04 Eingeleitet Mizuho Neutral
2024-10-08 Eingeleitet Stifel Buy
2024-10-07 Eingeleitet Piper Sandler Neutral
2024-09-26 Eingeleitet Wolfe Research Peer Perform
2024-09-05 Eingeleitet BTIG Research Neutral
2024-06-24 Eingeleitet Argus Hold
2024-05-30 Eingeleitet Goldman Sell
2024-05-10 Eingeleitet BofA Securities Neutral
2024-04-10 Eingeleitet Morgan Stanley Equal-Weight
2024-04-08 Eingeleitet Wells Fargo Equal Weight
2024-04-02 Eingeleitet Edward Jones Hold
Alle ansehen

Solventum Corp Aktie (SOLV) Neueste Nachrichten

pulisher
Oct 09, 2026

China Sterilization Equipment Market Outlook to 2033Chemical, Physical and Ultraviolet Sterilizers | Revenue, Volume and Pricing Trends Reveal Growth Opportunities - GlobeNewswire Inc.

Oct 09, 2026
pulisher
Oct 09, 2026

China Patient Examination Devices Market Size, Share, and Forecast to 2033Thermometers and Stethoscopes | Pricing Trends and Growth Opportunities Guide Expansion - GlobeNewswire Inc.

Oct 09, 2026
pulisher
Oct 08, 2026

Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive? - Zacks Investment Research

Oct 08, 2026
pulisher
Oct 08, 2026

Why Solventum (SOLV) is a Top Value Stock for the Long-Term - Zacks Investment Research

Oct 08, 2026
pulisher
Oct 08, 2026

Jefferies cuts Solventum stock price target to $34 on de-rating - Investing.com UK

Oct 08, 2026
pulisher
Oct 07, 2026

Bair Hugger warming system wins Coolest Thing Made in Minnesota award - The Business Journals

Oct 07, 2026
pulisher
Oct 07, 2026

US83444MAQ42 Bond Yield and Price — BONDSCOM:US83444MAQ42 - TradingView

Oct 07, 2026
pulisher
Oct 06, 2026

Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch

Oct 06, 2026
pulisher
Oct 06, 2026

Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why. - GlobeNewswire

Oct 06, 2026
pulisher
Oct 06, 2026

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises - Zacks Investment Research

Oct 06, 2026
pulisher
Oct 05, 2026

Solventum Corporation (SOLV) Stock Forecasts - Yahoo Finance

Oct 05, 2026
pulisher
Oct 05, 2026

Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names - Zacks Investment Research

Oct 05, 2026
pulisher
Oct 04, 2026

SOLN5957384 Bond Profile: Coupon and Redemption - TradingView

Oct 04, 2026
pulisher
Oct 03, 2026

SOLN5957404 Bond Profile: Coupon and Redemption - TradingView

Oct 03, 2026
pulisher
Oct 03, 2026

Solventum Corporation (SOLV) stock price, news, quote and history - Yahoo Finance Australia

Oct 03, 2026
pulisher
Sep 30, 2026

Solventum Corp. stock falls Wednesday, underperforms market - MarketWatch

Sep 30, 2026
pulisher
Sep 30, 2026

SOLN5759822 Bond Profile: Coupon and Redemption - TradingView

Sep 30, 2026
pulisher
Sep 30, 2026

ETFs Investing in Solventum Corporation Stocks - TradingView

Sep 30, 2026
pulisher
Sep 25, 2026

How Is Solventum's Stock Performance Compared to Other Healthcare Stocks - Barchart.com

Sep 25, 2026
pulisher
Sep 25, 2026

How Is Solventum's Stock Performance Compared to Other Healthcare Stocks - Yahoo Finance

Sep 25, 2026
pulisher
Sep 23, 2026

Solventum (NYSE:SOLV) Forms Tight Breakout Setup as Technical Strength Builds - ChartMill

Sep 23, 2026
pulisher
Sep 22, 2026

Solventum Corp (KB7.MU) latest press releases and corporate news - uk.finance.yahoo.com

Sep 22, 2026
pulisher
Sep 21, 2026

Solventum Corporation (SOLV) Investor Outlook: Evaluating a 5.72% Upside with Robust ROE Metrics - DirectorsTalk Interviews

Sep 21, 2026
pulisher
Sep 20, 2026

Solventum (SOLV) Q1 2026 Earnings Call Transcript - Fortune

Sep 20, 2026
pulisher
Sep 18, 2026

Solventum: Divesture Unlocking Upside In A Spinoff Revaluation Play (NYSE:SOLV) - Seeking Alpha

Sep 18, 2026
pulisher
Sep 17, 2026

Here's Why You Should Hold Solventum Stock in Your Portfolio for Now - Yahoo Finance

Sep 17, 2026
pulisher
Sep 16, 2026

Solventum Corp Lobbyists, 2026 - OpenSecrets

Sep 16, 2026
pulisher
Sep 16, 2026

Q2 Surgical Equipment & ConsumablesDiversified Earnings: Solventum (NYSE:SOLV) Impresses - Yahoo Finance

Sep 16, 2026
pulisher
Sep 16, 2026

What Solventum (SOLV)'s Earnings Beat and Surgical AI Push Means For Shareholders - Yahoo Finance

Sep 16, 2026
pulisher
Sep 10, 2026

Solventum Corp. stock falls Thursday, underperforms market - MarketWatch

Sep 10, 2026
pulisher
Sep 09, 2026

Solventum at Wells Fargo 21st Annual Healthcare Conference: focus narrows By Investing.com - Investing.com South Africa

Sep 09, 2026
pulisher
Sep 09, 2026

Solventum at Wells Fargo 21st Annual Healthcare Conference: focus narrows By Investing.com - Investing.com India

Sep 09, 2026
pulisher
Sep 09, 2026

Solventum at Wells Fargo 21st Annual Healthcare Conference: focus narrows - investing.com

Sep 09, 2026
pulisher
Sep 09, 2026

Solventum at Wells Fargo 21st Annual Healthcare Conference: focus narrows By Investing.com - Investing.com UK

Sep 09, 2026
pulisher
Sep 08, 2026

Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch

Sep 08, 2026
pulisher
Sep 04, 2026

Hanson Bryan C Reports 185,515 Shares in Solventum After Exercising Options and Forfeiture - Kalkine Media

Sep 04, 2026
pulisher
Sep 04, 2026

Solventum (SOLV) Up 11.4% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Sep 04, 2026
pulisher
Sep 03, 2026

Solventum CEO Bryan Hanson Completes RSU Settlement and Share Withholding on September 1, 2026 - Kalkine Media

Sep 03, 2026
pulisher
Sep 03, 2026

Is Solventum (SOLV) Fairly Valued On Raised 2026 Guidance Despite Debt And Cost Headwinds? - simplywall.st

Sep 03, 2026
pulisher
Sep 02, 2026

Solventum Corp. stock rises Wednesday, outperforms market - MarketWatch

Sep 02, 2026
pulisher
Sep 02, 2026

Solventum to Participate in the 2026 Wells Fargo Healthcare Conference - marketscreener.com

Sep 02, 2026
pulisher
Sep 02, 2026

Solventum to Participate in the 2026 Wells Fargo Healthcare Conference - finance.yahoo.com

Sep 02, 2026
pulisher
Sep 02, 2026

Should Investors Buy SOLV as Growth Improves but Debt Risks Persist? - Yahoo Finance

Sep 02, 2026
pulisher
Sep 01, 2026

Solventum Corp stock hits 52-week high at 93.6 USD - investing.com

Sep 01, 2026
pulisher
Sep 01, 2026

Solventum Corp stock hits 52-week high at 93.6 USD By Investing.com - Investing.com India

Sep 01, 2026
pulisher
Sep 01, 2026

Solventum Corp stock hits 52-week high at 93.6 USD By Investing.com - Investing.com South Africa

Sep 01, 2026
pulisher
Aug 24, 2026

Solventum Corp stock hits 52-week high at 90.05 USD - Investing.com India

Aug 24, 2026
pulisher
Aug 24, 2026

Solventum Corp stock hits 52-week high at 90.05 USD By Investing.com - Investing.com Canada

Aug 24, 2026
pulisher
Aug 24, 2026

Solventum Corp stock hits 52-week high at 90.05 USD By Investing.com - Investing.com Nigeria

Aug 24, 2026
pulisher
Aug 24, 2026

Solventum Corp stock hits 52-week high at 90.05 USD By Investing.com - Investing.com UK

Aug 24, 2026

Finanzdaten der Solventum Corp-Aktie (SOLV)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Solventum Corp-Aktie (SOLV) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
McMillan Wayde D.
Chief Financial Officer
May 13 '26
Option Exercise
0.00
9,503
0
53,041
Harrington Paul S
Chief Supply Chain Officer
May 13 '26
Option Exercise
0.00
3,960
0
22,130
Wilcox Mary T
Chief Accounting Officer
May 13 '26
Option Exercise
0.00
2,376
0
7,632
Kirberger Marcela A.
Chief Legal Affairs Officer
May 13 '26
Option Exercise
0.00
4,488
0
15,492
Hanson Bryan C
Chief Executive Officer
May 13 '26
Option Exercise
0.00
34,315
0
158,225
Landucci Amy
Chief Information Officer
May 13 '26
Option Exercise
0.00
4,422
0
41,905
Wendell Amy McBride
Director
Apr 30 '26
Option Exercise
0.00
3,403
0
10,422
WEILAND JOHN H
Director
Apr 30 '26
Option Exercise
0.00
3,403
0
8,947
Mily Elizabeth
Director
Apr 30 '26
Option Exercise
0.00
3,403
0
9,009
Wilson Darryl L.
Director
Apr 30 '26
Option Exercise
0.00
3,403
0
8,947
BAX BAX
$24.35
price up icon 1.88%
$173.88
price up icon 6.13%
$15.67
price up icon 1.82%
COO COO
$54.37
price up icon 0.13%
$142.71
price up icon 1.19%
ATR ATR
$120.38
price down icon 1.17%
Kapitalisierung:     |  Volumen (24h):